2011
DOI: 10.1161/hypertensionaha.110.166892
|View full text |Cite
|
Sign up to set email alerts
|

A Disintegrin and Metalloprotease 17 Mediates Neointimal Hyperplasia in Vasculature

Abstract: Summary The requirement of a metalloprotease ADAM17 (a disintegrin and metalloprotease 17) for the growth of cultured vascular smooth muscle cells has been demonstrated in vitro. However, whether this metalloprotease is responsible for vascular remodeling in vivo remains unanswered. Rat carotid arteries were analyzed 2 weeks after a balloon angioplasty. The neointimal cells were strongly positive for ADAM17 immunostaining. Marked inhibition of intimal hyperplasia was observed in dominant negative ADAM17 adenov… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
28
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

5
4

Authors

Journals

citations
Cited by 29 publications
(29 citation statements)
references
References 38 publications
(46 reference statements)
1
28
0
Order By: Relevance
“…A recent study showed that CaCl 2 -induced AAA did not develop in mice with inducible ADAM17 silencing [13]. Two major ADAM17 substrates likely mediating vascular remodeling are HB-EGF and TNF-α [11]. Our data demonstrated that EGFR activation is associated with AAA.…”
Section: Discussionmentioning
confidence: 49%
See 1 more Smart Citation
“…A recent study showed that CaCl 2 -induced AAA did not develop in mice with inducible ADAM17 silencing [13]. Two major ADAM17 substrates likely mediating vascular remodeling are HB-EGF and TNF-α [11]. Our data demonstrated that EGFR activation is associated with AAA.…”
Section: Discussionmentioning
confidence: 49%
“…This process relies on ADAM17 compartmentalization in caveolae and is crucial for vascular remodeling [10, 11]. In human AAA as well as in a mouse model where AAA is induced by aortic CaCl 2 application, significant up-regulation of ADAM17 has been reported [12].…”
Section: Introductionmentioning
confidence: 99%
“…Although we have not explored ADAM17 protease activity directly in vivo it is conceivable that the increase of its substrates in the circulation depends from increased enzymatic activity at local inflammatory sites. Therefore, to study ADAM17 activity in an atherosclerotic setting we decided to evaluate, among its many substrates [12,13], those that were already independently implicated in severity or complications of atherosclerosis [14], but never with a combined approach. We reasoned that local over-activity of ADAM17 may weaken atherosclerotic plaque, causing their rupture, as a consequence of enzyme activation promoted by well known cardiovascular risk factors such as hyperglycemia, hyperinsulinemia and oxidized LDL and consequent increase in intraplaque inflammatory cells trafficking [7,14e16].…”
Section: Discussionmentioning
confidence: 99%
“…The common carotid artery was extracted and fixed. Immunohistochemistry was performed as described previously 12 with Egr-1 antibody.…”
Section: Adenoviral Vectors and Infectionmentioning
confidence: 99%